These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials. Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471 [TBL] [Abstract][Full Text] [Related]
45. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group. Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967 [TBL] [Abstract][Full Text] [Related]
46. High antigenicity of intraperitoneal insulin infusion via implantable devices: preliminary rat studies. Jeandidier N; Boullu S; Delatte E; Sapin R; Steibel J; Meyer P; Uhl C; Pinget M Horm Metab Res; 2001 Jan; 33(1):34-8. PubMed ID: 11280713 [TBL] [Abstract][Full Text] [Related]
48. [In vivo evaluation of the new antithrombogenic reservoir-catheter coated with polymer blend copolymer]. Matsumoto S; Yamada Y; Kiyosue H; Dono S; Mori H; Imagawa M; Nomura Y; Toyoda H; Shimada T Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):238-43. PubMed ID: 9164111 [TBL] [Abstract][Full Text] [Related]
49. Delivering insulin 'round the clock. Fain JA Nursing; 2002 Aug; 32(8):54-6. PubMed ID: 12352854 [No Abstract] [Full Text] [Related]
50. Scintigraphic monitoring of catheter-port systems in type I diabetics with continuous insulin therapy. Lindner O; Klein E; Franzke K; Petzoldt R; Burchert W Exp Clin Endocrinol Diabetes; 2004 Mar; 112(3):148-52. PubMed ID: 15052535 [TBL] [Abstract][Full Text] [Related]
51. [Port visualization before intraperitoneal chemotherapy: scintigraphy or angiography?]. Brecht-Krauss D; Vogel J; Hepp G Rofo; 1991 Jun; 154(6):638-42. PubMed ID: 1648768 [TBL] [Abstract][Full Text] [Related]
52. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices. Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051 [TBL] [Abstract][Full Text] [Related]
53. Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump. Kessler L; Tritschler S; Bohbot A; Sigrist S; Karsten V; Boivin S; Dufour P; Belcourt A; Pinget M Diabetes Care; 2001 Feb; 24(2):302-7. PubMed ID: 11213883 [TBL] [Abstract][Full Text] [Related]
54. Experience of long-term intraperitoneal insulin treatment using a new percutaneous access device. Wredling R; Adamson U; Lins PE; Backman L; Lundgren D Diabet Med; 1991 Jul; 8(6):597-600. PubMed ID: 1832367 [TBL] [Abstract][Full Text] [Related]
55. An open-loop insulin delivery device for the control of experimental diabetes. Albisser AM; Jackman WS; Ferguson R; Bahoric A; Goriya Y Horm Metab Res Suppl; 1979; (8):51-7. PubMed ID: 395090 [TBL] [Abstract][Full Text] [Related]
56. Implantable insulin pump therapy: an unusual presentation of a catheter-related complication. Moore KB; Saudek CD; Greene A; Dackiw A Diabetes Technol Ther; 2006 Jun; 8(3):397-401. PubMed ID: 16800761 [TBL] [Abstract][Full Text] [Related]